Trinity Biotech (TRIB) Inventory Average (2009 - 2025)

Trinity Biotech has disclosed Inventory Average across 17 years of filings, most recently posting $19.5 million for Q4 2025.

• Inventory Average for Q4 2025 came in at $19.5 million, down 5.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.5 million (down 5.39% YoY), and the FY2025 annual result was $19.1 million, up 86.04% from the prior year.
• Inventory Average came in at $19.5 million for Q4 2025 at Trinity Biotech, down from $19.8 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $36.1 million in Q2 2021 to a low of $11.0 million in Q4 2023.
• The 5-year median for Inventory Average is $22.6 million (2024), against an average of $24.2 million.
• Across the five-year window, Inventory Average sank 52.15% in 2023 and surged 86.83% in 2024, its largest moves.
• Trinity Biotech's Inventory Average stood at $30.6 million in 2021, then dropped by 24.79% to $23.0 million in 2022, then tumbled by 52.15% to $11.0 million in 2023, then jumped by 86.83% to $20.6 million in 2024, then slipped by 5.39% to $19.5 million in 2025.
• The last three Inventory Average figures came in at $19.5 million (Q4 2025), $19.8 million (Q2 2025), and $20.6 million (Q4 2024), per Business Quant data.